Welcome to our dedicated page for Origin Agritech news (Ticker: SEED), a resource for investors and traders seeking the latest updates and insights on Origin Agritech stock.
Origin Agritech Limited develops agricultural technology and crop seed biotechnology in China, with news centered on corn seed R&D, genetic improvement, commercialization programs, and regulatory authorizations for crop seed production and GMO-related operations. Company updates frequently cover new corn varieties such as Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, as well as distributor initiatives including the Golden Harvest Club.
Recurring developments also include biotechnology pipeline work involving glyphosate tolerance, Bt pest-resistance traits, phytase corn, gene editing technology, research collaborations, market expansion in Chinese agricultural regions, annual results, financing actions, and board or finance leadership changes.
Origin Agritech Ltd. (NASDAQ: SEED) has signed a commercialization agreement with the Institute of Plant Protection of the Chinese Academy of Agricultural Sciences for a new insect-resistant GMO corn gene. This agreement follows over a decade of collaboration, allowing Origin to patent transgenic corn developed from the gene. Origin will manage the bio-safety certification process and holds exclusive worldwide commercialization rights, paying a single-digit percentage of sales royalties to IPP.
Origin Agritech Ltd. (NASDAQ: SEED) has announced that it has regained compliance with NASDAQ listing requirements after previously being non-compliant due to insufficient stockholders' equity, market value, and net income. On March 6, 2020, the company was notified of the deficiencies, but from July 2 to July 30, 2020, it maintained a market value of at least $35 million. The compliance notification marks a positive turnaround for the company, enhancing its standing on the NASDAQ Capital Market.
Origin Agritech Ltd. (NASDAQ: SEED) has partnered with the National Maize Improvement Center of China (NMICC) to develop and commercialize new GMO corn traits. This collaboration leverages NMICC's extensive experience, having produced 64 hybrid corn varieties grown on over 30 million hectares in China. The partnership aims to boost domestic corn production and reduce pesticide use by introducing innovative seed traits. This marks a significant step in Origin Agritech's expansion within the Chinese agricultural sector.
Origin Agritech Ltd. (NASDAQ: SEED) has announced a collaboration with the Biotechnology Research Institute (BRI) to enhance GMO soybean research and commercialization. This partnership will focus on developing GMO soybean varieties with enhanced drought and salt-alkaline tolerances, in addition to existing glyphosate tolerance traits. Origin has exclusive commercial rights to certain GMO crops developed by BRI. The agreement aims to boost soybean production and benefits farmers in China and globally.